Asia-Pacific Drug Delivery Devices Market Outlook to 2017

Summary
GlobalData's new report,  Asia-Pacific Drug Delivery Devices Market Outlook to 20
17 provides key market data on the Asia-Pacific Drug Delivery Devices market  Aust
ralia, China, India and Japan. The report provides value (USD million) data for
all the market categories  Central Venous Catheters, Infusion Systems, Metered Do
se Inhaler Devices and Needle Free Injections. The report also provides company
shares and distribution shares data for each of the aforementioned market catego
ries. The report is supplemented with global corporate-level profiles of the key
market participants.
This report is built using data and information sourced from proprietary databas
es, primary and secondary research and in-house analysis by GlobalData's team of
industry experts.
Scope
- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Drug Delivery Devices market categories
 Central Venous Catheters, Infusion Systems, Metered Dose Inhaler Devices and Ne
edle Free Injections.
- Annualized market revenues (USD million) data for each of the market categorie
s in each of the country. Data from 2003 to 2010, forecast forward for 7 years t
o 2017.
- 2010 company shares and distribution shares data for each of the market catego
ries and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pac
ific Drug Delivery Devices market..
- Key players covered include GlaxoSmithKline plc, Boehringer Ingelheim GmbH, As
traZeneca PLC, Terumo Corporation, Sunovion, NIPRO CORPORATION and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segme
nts poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Paci
fic Drug Delivery Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments e
xpected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of p
roduct distribution  Identify, understand and capitalize.

1.1 List of Tables

Table 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-201
7 12
Table 2: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), 2003-2017 14
Table 3: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, 2003-2017
15
Table 4: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), Historic, 20
03-2010 17
Table 5: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), Forecast, 20
10-2017 19
Table 6: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), 2003-2017
20
Table 7: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Historic,
 2003-2010 22
Table 8: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Forecast,
2010-2017 24
Table 9: Drug Delivery Devices, Asia-Pacific, Company share by Revenue ($m), 200
9-2010 26
Table 10: Drug Delivery Devices, Japan, Overall Revenue ($m), 2003-2017 28
Table 11: Drug Delivery Devices, Japan, Overall Revenue ($m), Historic, 2003-201
0 30
Table 12: Drug Delivery Devices, Japan, Overall Revenue ($m), Forecast, 2010-201
7 32
Table 13: Drug Delivery Devices, Japan, Category Volume (Units), 2003-2017 33
Table 14: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2003-
2010 35
Table 15: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2010-
2017 37
Table 16: Central Venous Catheters, Japan, Distribution Share by Revenue ($m), 2
009-2010 38
Table 17: Infusion Systems, Japan, Distribution Share by Revenue ($m), 2009-2010
38
Table 18: Metered Dose Inhaler Devices, Japan, Distribution Share by Revenue ($m
), 2009-2010 39
Table 19: Needle Free Injections, Japan, Distribution Share by Revenue ($m), 200
9-2010 39
Table 20: Drug Delivery Devices, Japan, Company Share by Revenue ($m), 2009-2010
41
Table 21: Central Venous Catheters, Japan, Company Share by Revenue ($m), 2009-2
010 43
Table 22: Infusion Systems, Japan, Company Share by Revenue ($m), 2009-2010 45
Table 23: Metered Dose Inhaler Devices, Japan, Company Share by Revenue ($m), 20
09-2010 46
Table 24: Needle Free Injections, Japan, Company Share by Revenue ($m), 2009-201
0 47
Table 25: Drug Delivery Devices, Australia, Overall Revenue ($m), 2003-2017 49
Table 26: Drug Delivery Devices, Australia, Overall Revenue ($m), Historic, 2003
-2010 51
Table 27: Drug Delivery Devices, Australia, Overall Revenue ($m), Forecast, 2010
-2017 53
Table 28: Drug Delivery Devices, Australia, Category Volume (Units), 2003-2017 5
4
Table 29: Drug Delivery Devices, Australia, Category Volume (Units), Historic, 2
003-2010 56
Table 30: Drug Delivery Devices, Australia, Category Volume (Units), Forecast, 2
010-2017 58
Table 31: Central Venous Catheters, Australia, Distribution Share by Revenue ($m
), 2009-2010 59
Table 32: Infusion Systems, Australia, Distribution Share by Revenue ($m), 2009-
2010 59
Table 33: Metered Dose Inhaler Devices, Australia, Distribution Share by Revenue
($m), 2009-2010 60
Table 34: Needle Free Injections, Australia, Distribution Share by Revenue ($m),
2009-2010 60
Table 35: Drug Delivery Devices, Australia, Company Share by Revenue ($m), 2009-
2010 62
Table 36: Central Venous Catheters, Australia, Company Share by Revenue ($m), 20
09-2010 64
Table 37: Infusion Systems, Australia, Company Share by Revenue ($m), 2009-2010
66
Table 38: Metered Dose Inhaler Devices, Australia, Company Share by Revenue ($m)
, 2009-2010 67
Table 39: Needle Free Injections, Australia, Company Share by Revenue ($m), 2009
-2010 68
Table 40: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 70
Table 41: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-201
0 72
Table 42: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-201
7 74
Table 43: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 75
Table 44: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003-
2010 77
Table 45: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010-
2017 79
Table 46: Central Venous Catheters, China, Distribution Share by Revenue ($m), 2
009-2010 80
Table 47: Infusion Systems, China, Distribution Share by Revenue ($m), 2009-2010
80
Table 48: Metered Dose Inhaler Devices, China, Distribution Share by Revenue ($m
), 2009-2010 81
Table 49: Needle Free Injections, China, Distribution Share by Revenue ($m), 200
9-2010 81
Table 50: Drug Delivery Devices, China, Company Share by Revenue ($m), 2009-2010
83
Table 51: Central Venous Catheters, China, Company Share by Revenue ($m), 2009-2
010 85
Table 52: Infusion Systems, China, Company Share by Revenue ($m), 2009-2010 87
Table 53: Metered Dose Inhaler Devices, China, Company Share by Revenue ($m), 20
09-2010 89
Table 54: Needle Free Injections, China, Company Share by Revenue ($m), 2009-201
0 90
Table 55: Drug Delivery Devices, India, Overall Revenue ($m), 2003-2017 92
Table 56: Drug Delivery Devices, India, Overall Revenue ($m), Historic, 2003-201
0 94
Table 57: Drug Delivery Devices, India, Overall Revenue ($m), Forecast, 2010-201
7 96
Table 58: Drug Delivery Devices, India, Category Volume (Units), 2003-2017 97
Table 59: Drug Delivery Devices, India, Category Volume (Units), Historic, 2003-
2010 99
Table 60: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2010-
2017 101
Table 61: Central Venous Catheters, India, Distribution Share by Revenue ($m), 2
009-2010 102
Table 62: Infusion Systems, India, Distribution Share by Revenue ($m), 2009-2010
102
Table 63: Metered Dose Inhaler Devices, India, Distribution Share by Revenue ($m
), 2009-2010 103
Table 64: Needle Free Injections, India, Distribution Share by Revenue ($m), 200
9-2010 103
Table 65: Drug Delivery Devices, India, Company Share by Revenue ($m), 2009-2010
105
Table 66: Central Venous Catheters, India, Company Share by Revenue ($m), 2009-2
010 107
Table 67: Infusion Systems, India, Company Share by Revenue ($m), 2009-2010 109
Table 68: Metered Dose Inhaler Devices, India, Company Share by Revenue ($m), 20
09-2010 111
Table 69: Drug Delivery Devices Market Pipeline Products 124
Table 70: USD to Local Currency, Asia-Pacific, Average Exchange Rate 2003-2010 1
32
1.2 List of Figures
Figure 1: Drug Delivery Devices, Cross Country Comparison, Revenue ($m), 2003-20
17 12
Figure 2: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), 2003-2017 1
3
Figure 3: Drug Delivery Devices, Asia-Pacific, Cross-Category Analysis, 2003-201
7 15
Figure 4: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), Historic, 2
003-2010 16
Figure 5: Drug Delivery Devices, Asia-Pacific, Overall Revenue ($m), Forecast, 2
010-2017 18
Figure 6: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), 2003-201
7 20
Figure 7: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Historic
, 2003-2010 21
Figure 8: Drug Delivery Devices, Asia-Pacific, Category Volume (Units), Forecast
, 2010-2017 23
Figure 9: Drug Delivery Devices, Asia-Pacific, Company share (%), 2010 25
Figure 10: Drug Delivery Devices, Japan, Overall Revenue ($m), 2003-2017 27
Figure 11: Drug Delivery Devices, Japan, Overall Revenue ($m), Historic, 2003-20
10 29
Figure 12: Drug Delivery Devices, Japan, Overall Revenue ($m), Forecast, 2010-20
17 31
Figure 13: Drug Delivery Devices, Japan, Category Volume (Units), 2003-2017 33
Figure 14: Drug Delivery Devices, Japan, Category Volume (Units), Historic, 2003
-2010 34
Figure 15: Drug Delivery Devices, Japan, Category Volume (Units), Forecast, 2010
-2017 36
Figure 16: Drug Delivery Devices, Japan, Company Share (%), 2010 40
Figure 17: Central Venous Catheters, Japan, Company Share (%), 2010 42
Figure 18: Infusion Systems, Japan, Company Share (%), 2010 44
Figure 19: Metered Dose Inhaler Devices, Japan, Company Share (%), 2010 46
Figure 20: Needle Free Injections, Japan, Company Share (%), 2010 47
Figure 21: Drug Delivery Devices, Australia, Overall Revenue ($m), 2003-2017 48
Figure 22: Drug Delivery Devices, Australia, Overall Revenue ($m), Historic, 200
3-2010 50
Figure 23: Drug Delivery Devices, Australia, Overall Revenue ($m), Forecast, 201
0-2017 52
Figure 24: Drug Delivery Devices, Australia, Category Volume (Units), 2003-2017
54
Figure 25: Drug Delivery Devices, Australia, Category Volume (Units), Historic,
2003-2010 55
Figure 26: Drug Delivery Devices, Australia, Category Volume (Units), Forecast,
2010-2017 57
Figure 27: Drug Delivery Devices, Australia, Company Share (%), 2010 61
Figure 28: Central Venous Catheters, Australia, Company Share (%), 2010 63
Figure 29: Infusion Systems, Australia, Company Share (%), 2010 65
Figure 30: Metered Dose Inhaler Devices, Australia, Company Share (%), 2010 67
Figure 31: Needle Free Injections, Australia, Company Share (%), 2010 68
Figure 32: Drug Delivery Devices, China, Overall Revenue ($m), 2003-2017 69
Figure 33: Drug Delivery Devices, China, Overall Revenue ($m), Historic, 2003-20
10 71
Figure 34: Drug Delivery Devices, China, Overall Revenue ($m), Forecast, 2010-20
17 73
Figure 35: Drug Delivery Devices, China, Category Volume (Units), 2003-2017 75
Figure 36: Drug Delivery Devices, China, Category Volume (Units), Historic, 2003
-2010 76
Figure 37: Drug Delivery Devices, China, Category Volume (Units), Forecast, 2010
-2017 78
Figure 38: Drug Delivery Devices, China, Company Share (%), 2010 82
Figure 39: Central Venous Catheters, China, Company Share (%), 2010 84
Figure 40: Infusion Systems, China, Company Share (%), 2010 86
Figure 41: Metered Dose Inhaler Devices, China, Company Share (%), 2010 88
Figure 42: Needle Free Injections, China, Company Share (%), 2010 90
Figure 43: Drug Delivery Devices, India, Overall Revenue ($m), 2003-2017 91
Figure 44: Drug Delivery Devices, India, Overall Revenue ($m), Historic, 2003-20
10 93
Figure 45: Drug Delivery Devices, India, Overall Revenue ($m), Forecast, 2010-20
17 95
Figure 46: Drug Delivery Devices, India, Category Volume (Units), 2003-2017 97
Figure 47: Drug Delivery Devices, India, Category Volume (Units), Historic, 2003
-2010 98
Figure 48: Drug Delivery Devices, India, Category Volume (Units), Forecast, 2010
-2017 100
Figure 49: Drug Delivery Devices, India, Company Share (%), 2010 104
Figure 50: Central Venous Catheters, India, Company Share (%), 2010 106
Figure 51: Infusion Systems, India, Company Share (%), 2010 108
Figure 52: Metered Dose Inhaler Devices, India, Company Share (%), 2010 110
Figure 53: GlaxoSmithKline plc, Company Share (%), Asia-Pacific Drug Delivery De
vices Market, 2010 112
Figure 54: Boehringer Ingelheim GmbH, Company Share (%), Asia-Pacific Drug Deliv
ery Devices Market, 2010 113
Figure 55: AstraZeneca PLC, Company Share (%), Asia-Pacific Drug Delivery Device
s Market, 2010 114
Figure 56: Terumo Corporation, Company Share (%), Asia-Pacific Drug Delivery Dev
ices Market, 2010 115
Figure 57: Sunovion, Company Share (%), Asia-Pacific Drug Delivery Devices Marke
t, 2010 116
Figure 58: Baxter International Inc, Company Share (%), Asia-Pacific Drug Delive
ry Devices Market, 2010 117